312 related articles for article (PubMed ID: 1615139)
1. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
Lange KW; Robbins TW; Marsden CD; James M; Owen AM; Paul GM
Psychopharmacology (Berl); 1992; 107(2-3):394-404. PubMed ID: 1615139
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
Lange KW; Paul GM; Naumann M; Gsell W
J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
[TBL] [Abstract][Full Text] [Related]
3. Fronto-striatal cognitive deficits at different stages of Parkinson's disease.
Owen AM; James M; Leigh PN; Summers BA; Marsden CD; Quinn NP; Lange KW; Robbins TW
Brain; 1992 Dec; 115 ( Pt 6)():1727-51. PubMed ID: 1486458
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM
Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615
[TBL] [Abstract][Full Text] [Related]
5. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.
Robbins TW; James M; Owen AM; Lange KW; Lees AJ; Leigh PN; Marsden CD; Quinn NP; Summers BA
J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):79-88. PubMed ID: 8301310
[TBL] [Abstract][Full Text] [Related]
6. Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease.
Mollion H; Ventre-Dominey J; Dominey PF; Broussolle E
Neuropsychologia; 2003; 41(11):1442-51. PubMed ID: 12849762
[TBL] [Abstract][Full Text] [Related]
7. Cognitive performance in multiple system atrophy.
Robbins TW; James M; Lange KW; Owen AM; Quinn NP; Marsden CD
Brain; 1992 Feb; 115 Pt 1():271-91. PubMed ID: 1559159
[TBL] [Abstract][Full Text] [Related]
8. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease.
Mehta MA; Sahakian BJ; McKenna PJ; Robbins TW
Psychopharmacology (Berl); 1999 Sep; 146(2):162-74. PubMed ID: 10525751
[TBL] [Abstract][Full Text] [Related]
9. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.
Owen AM; Roberts AC; Hodges JR; Summers BA; Polkey CE; Robbins TW
Brain; 1993 Oct; 116 ( Pt 5)():1159-75. PubMed ID: 8221053
[TBL] [Abstract][Full Text] [Related]
10. L-dopa and frontal cognitive function in Parkinson's disease.
Lange KW; Paul GM; Robbins TW; Marsden CD
Adv Neurol; 1993; 60():475-8. PubMed ID: 8420173
[No Abstract] [Full Text] [Related]
11. Levodopa medication improves incidental sequence learning in Parkinson's disease.
Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
[TBL] [Abstract][Full Text] [Related]
12. Frontal-striatal cognitive deficits in patients with chronic schizophrenia.
Pantelis C; Barnes TR; Nelson HE; Tanner S; Weatherley L; Owen AM; Robbins TW
Brain; 1997 Oct; 120 ( Pt 10)():1823-43. PubMed ID: 9365373
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
[TBL] [Abstract][Full Text] [Related]
14. Visuospatial memory deficits at different stages of Parkinson's disease.
Owen AM; Beksinska M; James M; Leigh PN; Summers BA; Marsden CD; Quinn NP; Sahakian BJ; Robbins TW
Neuropsychologia; 1993 Jul; 31(7):627-44. PubMed ID: 8371837
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
Hanna-Pladdy B; Pahwa R; Lyons KE
J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
[TBL] [Abstract][Full Text] [Related]
16. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery.
Robbins TW; James M; Owen AM; Sahakian BJ; Lawrence AD; McInnes L; Rabbitt PM
J Int Neuropsychol Soc; 1998 Sep; 4(5):474-90. PubMed ID: 9745237
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
[TBL] [Abstract][Full Text] [Related]
18. Effect of levodopa on frontal-subcortical and posterior cortical functioning in patients with Parkinson's disease.
Gul A; Yousaf J
Singapore Med J; 2019 Aug; 60(8):414-417. PubMed ID: 30246215
[TBL] [Abstract][Full Text] [Related]
19. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed.
Beats BC; Sahakian BJ; Levy R
Psychol Med; 1996 May; 26(3):591-603. PubMed ID: 8733217
[TBL] [Abstract][Full Text] [Related]
20. L-dopa impairs learning, but spares generalization, in Parkinson's disease.
Shohamy D; Myers CE; Geghman KD; Sage J; Gluck MA
Neuropsychologia; 2006; 44(5):774-84. PubMed ID: 16150469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
